NCT00136760View on ClinicalTrials.gov

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
Interventions
DRUG

Bupropion

Contingent reinforcement plus bupropion (300 mg/day for 3 weeks)

DRUG

Contingent reinforcement plus placebo

contingent reinforcement plus placebo (3 weeks)

DRUG

non-contingent reinforcement plus bupropion

non-contingent reinforcement plus bupropion (300 mg/day for 3 weeks)

DRUG

Non-contingent reinforcement plus placebo

Non-contingent reinforcement plus placebo

Trial Locations (1)

02912

Brown University, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Brown University

OTHER